SOPHiA GENETICS SA

US$7.14As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SOPHHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (13.83%)
Div yield —
ROE (125.67%)
Health Information Services
Beta (5Y) 1.09
PE TTM —
TSR TTM 42.80%
Mkt cap US$611.6M
ROIC (36.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.22
15.15%
(24.81%)
Buy 6|2|7|0|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.16
0.17
0.17
26.31%
10.12%
7.22%
7.76%
Revenue$M
63.69
64.19
66.60
67.63
15.11%
10.07%
11.26%
11.82%
Peers (US$611.6M)
Cap (US$)
PE
1.490B
—
1.022B
—
221.2M
10.32x
Capital
TTM
5Y
10Y
Leveragex
0.874
0.288
0.235
EBIT/Intx
0.917
0.349
0.361
Own earn%
(215.57)
(43.91)
(42.45)
Sh yield%
43.06
20.88
25.13
Owners
Insiders/Inst%
12.89
59.84
Short interest%
2.77
SBC / revenue%
4.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
14–19
$1 testx
0.3
Incr. ROIC%
0